Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
PLoS One ; 5(11): e13824, 2010 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-21072206

RESUMO

The causes of dolphin and whale stranding can often be difficult to determine. Because toothed whales rely on echolocation for orientation and feeding, hearing deficits could lead to stranding. We report on the results of auditory evoked potential measurements from eight species of odontocete cetaceans that were found stranded or severely entangled in fishing gear during the period 2004 through 2009. Approximately 57% of the bottlenose dolphins and 36% of the rough-toothed dolphins had significant hearing deficits with a reduction in sensitivity equivalent to severe (70-90 dB) or profound (>90 dB) hearing loss in humans. The only stranded short-finned pilot whale examined had profound hearing loss. No impairments were detected in seven Risso's dolphins from three different stranding events, two pygmy killer whales, one Atlantic spotted dolphin, one spinner dolphin, or a juvenile Gervais' beaked whale. Hearing impairment could play a significant role in some cetacean stranding events, and the hearing of all cetaceans in rehabilitation should be tested.


Assuntos
Golfinhos/fisiologia , Ecolocação/fisiologia , Perda Auditiva/fisiopatologia , Baleias/fisiologia , Fatores Etários , Animais , Audiometria/métodos , Golfinhos/classificação , Feminino , Humanos , Masculino , Especificidade da Espécie , Baleias/classificação
2.
J Zoo Wildl Med ; 33(1): 66-72, 2002 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12216796

RESUMO

Atropine, an anticholinergic agent commonly used in human and veterinary medicine, is reported to cause toxicity associated with its antimuscarinic action. A juvenile pygmy sperm whale, Kogia breviceps, was treated with atropine in an attempt to relieve symptoms similar to pyloric stenosis, as has been used in humans. Two doses of 0.01 mg/kg were given i.m., 12 hr apart, followed by three doses of 0.005 mg/kg i.m. s.i.d. over the next 3 days. Symptoms associated with atropine toxicity developed gradually and included hyperexcitability, a generalized ascending paralysis of body musculature, shallow, rapid respiration, vomiting, aspiration of seawater, and pulmonary edema. Treatment with physostigmine salicylate (two doses of 2 mg i.m., I hr apart) was effective in counteracting the paralysis, as well as other symptoms, beginning in as little as 17 min after the first dose, and the whale was back to swimming on its own after 8 hr. All overt symptoms of atropine toxicity were gone in about 24 hr, but there were other possible sequella that lasted much longer.


Assuntos
Atropina/efeitos adversos , Comportamento Animal/efeitos dos fármacos , Antagonistas Muscarínicos/efeitos adversos , Estenose Pilórica/veterinária , Baleias/fisiologia , Animais , Atropina/administração & dosagem , Atropina/sangue , Inibidores da Colinesterase/administração & dosagem , Diuréticos/administração & dosagem , Quimioterapia Combinada , Evolução Fatal , Furosemida/administração & dosagem , Frequência Cardíaca/efeitos dos fármacos , Masculino , Antagonistas Muscarínicos/administração & dosagem , Antagonistas Muscarínicos/sangue , Paralisia/induzido quimicamente , Paralisia/tratamento farmacológico , Paralisia/veterinária , Fisostigmina/administração & dosagem , Estenose Pilórica/tratamento farmacológico , Respiração/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...